consist of operating and administrative expenses, bad debt and doubtful accounts, and finance cost. In the fiscal year 2016, the Company had total consolidated expenses of 14,737 million baht, increased by
administrative expenses Expected credit loss Finance costs Other expenses 1,921 1,226 453 2 1,987 1,619 418 3 2,033 1,563 437 2 2% -3% 5% -33% 6% 28% -4% 0% 1,732 872 471 1 1,853 1,530 458 2 7% 75% -3% 100% Total
consolidated expected credit loss in the fiscal year of 20 22 amounted to 7,263 million baht, increasing by 9.6% y-y. - Finance Cost In 2022, the results of the Monetary Policy Committee (MPC) meeting resolved
No. ECF2 035/2562 23 September 2562 Subject Notification on the resolutions of the Board of Directors’ Meeting approving the purchase of the ordinary shares in KPN Academy Company Limited, the
the year ended December 31, 2019 To Director and Manager the Stock Exchange of Thailand According to the Board of Directors’ Meeting No.2/ 2 0 2 0 of DOD Biotech Public Company Limited ( “ the Company
Stock Exchange of Thailand Dear Sir, With reference to the Minutes 11/2017 of the Company Directors’ meeting dated November 13, 2017, the Board resolved to approve the reviewed financial statements of
; According to the Board of Directors’ Meeting of Oishi Group Public Company Limited No. 1/2016, which was held on 25 February 2016, has approved the change in the Company’s accounting period from 1 January and
25.5% Total Revenue 774.5 689.6 12.3% 775.2 -0.1% Selling and Administrative expenses 304.4 267.3 13.9% 326.9 -6.9% Profit before interest & tax 121.0 100.1 20.9% 93.2 29.8% % 15.6% 14.5% 12.0% Finance
digital asset business operators Pursuant to the Emergency Decree on Digital Asset Businesses of 2018, digital asset business operators are required to obtain a relevant license from the Minister of Finance